--- title: "Jiangsu Hanbon Science and Technology Co., Ltd. (688755.SH)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/688755.SH.md" symbol: "688755.SH" name: "Jiangsu Hanbon Science and Technology Co., Ltd." industry: "Life Sciences Tools and Services" datetime: "2026-05-20T08:13:36.339Z" locales: - [en](https://longbridge.com/en/quote/688755.SH.md) - [zh-CN](https://longbridge.com/zh-CN/quote/688755.SH.md) - [zh-HK](https://longbridge.com/zh-HK/quote/688755.SH.md) --- # Jiangsu Hanbon Science and Technology Co., Ltd. (688755.SH) ## Company Overview Jiangsu Hanbon Science and Technology Co., Ltd. engages in the research and development, production, and sale of liquid chromatography products in China and internationally. The company offers biopharm purification equipment, including chromatography column products, chromatography systems, buffer dilution/conditioning systems, filtration systems, and single-use systems; bio-oligo synthesizer products, such as nucleic acid synthesizer and oligonucleotide synthesis column products; and preparative liquid chromatography system and chromatographic column products. It also provides continuous chromatographic systems comprising simulated moving bed and continuous Ion exchange chromatography products; and supercritical fluid chromatography products, including analytical supercritical fluid chromatography, SFC-dynamic axial compression column, and CO2 booster station products. | Item | Detail | |------|--------| | Industry | Life Sciences Tools and Services | | Exchange | CN Market | | Website | [www.hanbon.com.cn](https://www.hanbon.com.cn) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: B > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-05-20T04:30:09.000Z **Overall: B (0.40)** **Industry**: Life Sciences Tools and Services | Metric | Value | |--------|-------| | Industry Ranking | 13 / 25 | | Industry Median | B | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: B #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 6.44% | | | Net Profit YoY | -20.90% | | | P/B Ratio | 2.75 | | | Dividend Ratio | 0.25% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 3490116867.71 | | | Revenue | 765910451.26 | | #### Multi Score Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 6.63% | C | | Profit Margin | 8.76% | B | | Gross Margin | 37.73% | B | | Revenue YoY | 6.44% | C | | Net Profit YoY | -20.90% | D | | Total Assets YoY | 47.05% | A | | Net Assets YoY | 67.57% | A | | Cash Flow Margin | 192.53% | B | | OCF YoY | 6.44% | C | | Turnover | 0.47 | C | | Gearing Ratio | 34.90% | B | ```chart-data:radar { "title": "Longbridge Financial Score - Jiangsu Hanbon Science and Technology Co., Ltd.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "6.44%", "rating": "" }, { "name": "Net Profit YoY", "value": "-20.90%", "rating": "" }, { "name": "P/B Ratio", "value": "2.75", "rating": "" }, { "name": "Dividend Ratio", "value": "0.25%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "3490116867.71", "rating": "" }, { "name": "Revenue", "value": "765910451.26", "rating": "" } ] }, { "name": "Multi Score", "grade": "B", "indicators": [ { "name": "ROE", "value": "6.63%", "rating": "C" }, { "name": "Profit Margin", "value": "8.76%", "rating": "B" }, { "name": "Gross Margin", "value": "37.73%", "rating": "B" }, { "name": "Revenue YoY", "value": "6.44%", "rating": "C" }, { "name": "Net Profit YoY", "value": "-20.90%", "rating": "D" }, { "name": "Total Assets YoY", "value": "47.05%", "rating": "A" }, { "name": "Net Assets YoY", "value": "67.57%", "rating": "A" }, { "name": "Cash Flow Margin", "value": "192.53%", "rating": "B" }, { "name": "OCF YoY", "value": "6.44%", "rating": "C" }, { "name": "Turnover", "value": "0.47", "rating": "C" }, { "name": "Gearing Ratio", "value": "34.90%", "rating": "B" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 52.00 | 8/25 | 54.30 | 50.27 | 48.32 | | PB | 2.75 | 8/25 | 3.45 | 3.12 | 2.87 | | PS (TTM) | 4.56 | 7/25 | 5.75 | 5.32 | 4.88 | | Dividend Yield | 0.25% | 14/25 | 0.25% | 0.25% | 0.23% | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B | | 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B | | 03 | Chemexpress (688131.SH) | B | B | C | C | B | B | | 04 | HitGen (688222.SH) | B | A | D | B | C | B | | 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B | ## Institutional View ### Analyst Rating Distribution > As of 2025-08-27T16:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 100% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 38.81 | | Highest Target | 55.00 | | Lowest Target | 55.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688755.SH/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688755.SH/norm.md) - [Related News](https://longbridge.com/en/quote/688755.SH/news.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**